13F Holdings
中文EN

OLN OLIN Corp

Chemicals & Allied Products · NYSE · SEC CIK 74303 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-0.7%
TTM net income YoY-531.2%
TTM EPS YoY-519.1%
Revenue 3-yr CAGR-2.2%
Net income 3-yr CAGR—

Margins

Gross margin6.7%
Operating margin-1.9%
Net margin-3.3%
FCF margin3.3%
EBITDA margin5.2%

Returns

ROE-12.2%
ROA-3.0%
ROIC (approx.)-2.2%
Asset turnover0.90x

Leverage & solvency

Liabilities / assets76.8%
Debt / equity1.75x
Current ratio1.45x
Interest coverage-0.71x

Cash quality & payout

Operating cash flow / net income-1.74x
Accruals ratio-8.2%
Payout ratio—
Capex / revenue2.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$6.78B$6.54B$6.83B$9.38B$8.91B
Cost of revenue$6.28B$5.80B$5.67B$7.19B$6.62B
Gross profit$501.50M$737.50M$1.17B$2.18B$2.29B
SG&A expense$463.30M$408.50M$406.70M$393.90M$416.90M
Operating income$5.30M$296.50M$712.10M$1.78B$1.85B
Interest expense$188.30M$184.50M$181.10M$143.90M$348.00M
Pretax income-$161.10M$141.70M$559.30M$1.68B$1.54B
Income tax-$60.00M$36.70M$107.30M$349.10M$242.00M
Net income-$101.10M$105.00M$452.00M$1.33B$1.30B
EBITDA$526.90M$814.60M$1.25B$2.38B$2.43B
EPS (basic)-0.880.923.669.168.15
EPS (diluted)-0.880.913.578.947.96
Weighted avg. shares (diluted)114.60M119.50M128.80M148.50M163.00M
Balance sheet
Cash & equivalents$167.60M$175.60M$170.30M$194.00M$180.50M
Short-term investments$0$0$0$0$0
Inventory$784.50M$823.50M$858.80M$941.90M$868.30M
Current assets$1.97B$2.08B$1.97B$2.16B$2.25B
PP&E, net$2.20B$2.33B$2.52B$2.67B$2.91B
Goodwill$1.43B$1.42B$1.42B$1.42B$1.42B
Intangibles$174.40M$206.60M$245.80M$273.80M$331.70M
Total assets$7.33B$7.58B$7.71B$8.04B$8.52B
Current liabilities$1.63B$1.63B$1.53B$1.56B$1.68B
Short-term debt$109.70M$129.00M$78.80M$9.70M$201.10M
Long-term debt$2.72B$2.71B$2.59B$2.57B$2.58B
Total debt$2.83B$2.84B$2.67B$2.58B$2.78B
Total liabilities$5.46B$5.52B$5.44B$5.50B$5.87B
Shareholders' equity$1.84B$2.02B$2.23B$2.54B$2.65B
Net debt$2.66B$2.67B$2.50B$2.39B$2.60B
Shares outstanding113.60M115.70M120.20M132.30M156.80M
Cash flow statement
Operating cash flow$474.20M$503.20M$974.30M$1.92B$1.74B
Capital expenditure$226.30M$195.10M$236.00M$236.90M$200.60M
Free cash flow$247.90M$308.10M$738.30M$1.69B$1.54B
Investing cash flow-$319.60M-$283.70M-$340.80M-$259.70M-$197.40M
Financing cash flow-$163.00M-$212.60M-$656.90M-$1.65B-$1.55B
Depreciation & amortization$521.60M$518.10M$533.40M$598.80M$582.50M
Stock-based compensation$20.70M$17.10M$18.60M$14.10M$8.30M
Dividends paid$91.60M$94.20M$101.00M$116.20M$127.80M
Share buybacks$50.50M$300.30M$711.30M$1.35B$251.90M

Free plan shows the latest 5 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.